학술논문

Response, Peak and Persistence of Varnimcabtagene Autoleucel (IMN-003A), First-in-India Industry CD19-Directed CAR-T Cell Therapy, with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies: Early Results (IMAGINE Study)
Document Type
Abstract
Source
In Blood 15 November 2022 140 Supplement 1:7478-7479
Subject
Language
ISSN
0006-4971